ATWA
ABBV icon

Arbor Trust Wealth Advisors’s AbbVie ABBV Stock Holding History

Arbor Trust Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.35M Sell
43,006
-1,688
-4% -$374K 4.11% 5
2025
Q4 		$10.2M Sell
44,694
-363
-0.8% -$82.7K 4.47% 5
2025
Q3 		$10.4M Sell
45,057
-33
-0.1% -$6.72K 4.7% 4
2025
Q2 		$8.37M Sell
45,090
-527
-1% -$97.9K 4.09% 5
2025
Q1 		$9.56M Buy
45,617
+119
+0.3% +$23.1K 4.48% 3
2024
Q4 		$8.09M Sell
45,498
-622
-1% -$114K 3.79% 6
2024
Q3 		$7.91M Hold
46,120
– – 4.15% 4
2024
Q2 		$7.91M Sell
46,120
-446
-1% -$73.9K 4.15% 4
2024
Q1 		$7.87M Buy
46,566
+13
+0% +$2.24K 4.32% 4
2023
Q4 		$7.21M Buy
46,553
+225
+0.5% +$32.8K 4.29% 4
2023
Q3 		$6.91M Buy
46,328
+275
+0.6% +$40.4K 4.55% 3
2023
Q2 		$6.2M Buy
46,053
+13
+0% +$1.91K 3.95% 6
2023
Q1 		$7.34M Buy
46,040
+165
+0.4% +$25.2K 4.82% 2
2022
Q4 		$7.41M Buy
45,875
+218
+0.5% +$33.4K 5.12% 2
2022
Q3 		$6.12M Buy
45,657
+65
+0.1% +$9.33K 4.66% 2
2022
Q2 		$6.98M Sell
45,592
-1,473
-3% -$225K 4.87% 2
2022
Q1 		$7.63M Buy
47,065
+1,113
+2% +$162K 4.58% 4
2021
Q4 		$6.22M Buy
45,952
+104
+0.2% +$12.3K 3.59% 7
2021
Q3 		$4.95M Buy
45,848
+72
+0.2% +$8.23K 3.09% 8
2021
Q2 		$5.16M Sell
45,776
-506
-1% -$57K 3.24% 7
2021
Q1 		$5.01M Buy
46,282
+840
+2% +$89.8K 3.35% 7
2020
Q4 		$4.87M Sell
45,442
-200
-0.4% -$19.2K 3.54% 7
2020
Q3 		$4M Sell
45,642
-2,045
-4% -$193K 3.46% 8
2020
Q2 		$4.68M Sell
47,687
-656
-1% -$57.8K 4.23% 4
2020
Q1 		$3.68M Buy
48,343
+155
+0.3% +$13.2K 3.89% 7
2019
Q4 		$4.27M Buy
+48,188
New +$4M 3.65% 7

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arbor Trust Wealth Advisors's ABBV Position: Q1 2026 in Review

Arbor Trust Wealth Advisors reduced its AbbVie (ABBV) stake by 3.8% in Q1 2026, selling an estimated $374K and leaving 43,006 shares worth $9.35M. The position accounts for 4.11% of the portfolio, ranked #5.

Arbor Trust Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $10.4M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Arbor Trust Wealth Advisors held 43,006 shares of AbbVie worth $9.35M as of Q1 2026.
  • Arbor Trust Wealth Advisors sold 1,688 AbbVie shares in Q1 2026, an estimated $374K.
  • AbbVie made up 4.11% of Arbor Trust Wealth Advisors's portfolio in Q1 2026, its #5 holding.
  • Arbor Trust Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Arbor Trust Wealth Advisors's AbbVie position peaked at $10.4M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Arbor Trust Wealth Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.